2
Clinical Trials associated with VGN-R13 / RecruitingEarly Phase 1IIT An Open, Dose-Escalation Early Phase Clinical Study to Evaluate the Tolerability, Safety, and Efficacy of Intrathecal of VGN-R13 in Patients with Amyotrophic Lateral Sclerosis (ALS)
The purpose of this trial is to evaluate safety and efficacy of intrathecal delivery of VGN-R13 as a treatment of Amyotrophic Lateral Sclerosis (ALS).
Start Date16 Jan 2025 |
Sponsor / Collaborator- |
/ RecruitingNot ApplicableIIT An Open, Dose-Escalation Early Phase Clinical Study to Evaluate the Tolerability, Safety, and Efficacy of Intrathecal of VGN-R13 in Patients With Amyotrophic Lateral Sclerosis (ALS)
100 Clinical Results associated with VGN-R13
100 Translational Medicine associated with VGN-R13
100 Patents (Medical) associated with VGN-R13
100 Deals associated with VGN-R13